SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-060826
Filing Date
2019-11-07
Accepted
2019-11-07 07:31:35
Documents
55
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-17598_110q.htm 10-Q 1086027
2 EX-10.1 a19-17598_1ex10d1.htm EX-10.1 679400
3 EX-31.1 a19-17598_1ex31d1.htm EX-31.1 12136
4 EX-32.1 a19-17598_1ex32d1.htm EX-32.1 4789
11 GRAPHIC g175981kg13i001.jpg GRAPHIC 4244
12 GRAPHIC g175981kg11i001.jpg GRAPHIC 44492
  Complete submission text file 0001104659-19-060826.txt   5376241

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT catb-20190930.xml EX-101.INS 1070000
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT catb-20190930.xsd EX-101.SCH 34114
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT catb-20190930_cal.xml EX-101.CAL 41215
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT catb-20190930_lab.xml EX-101.LAB 325080
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT catb-20190930_pre.xml EX-101.PRE 217740
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT catb-20190930_def.xml EX-101.DEF 94936
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 191198153
SIC: 2834 Pharmaceutical Preparations